Other investigators found that DSF/Cu inhibits cell growth and proliferation of ALDH-positive breast cancer by lowering expression of ALDH [31]; the specific mechanism may involve activating ROS generation and then blockading downstream cytokine NF-κβ[43]. Here, NFKB1 is linked to breast carcinoma.